
Currently out of the existing stock ratings of David Steinberg, 162 are a BUY (86.17%), 25 are a HOLD (13.3%), 1 are a SELL (0.53%).
Analyst David Steinberg, has had 69.27% of price targets met with an average potential upside of 30.99%, reached in 298 days on average. Previously, David Steinberg worked at JEFFERIES.
David Steinberg has documented 365 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZTS, Zoetis at 17-Feb-2022.
Analyst best performing recommendations are on SGNT (SAGENT PHARMACEUTICALS).
The best stock recommendation documented was for SUPN (SUPERNUS PHARMACEUTICALS) on 6/15/2020. The price target of $24 was fulfilled within 1 day with a profit of $0.93 (4.03%), with a performance score of 40.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 27-May-2025
$3
$-0.61 (-16.90%)
$8
2 days ago
(16-Nov-2026)
Buy Since 13-May-2025
$16
$12.39 (343.21%)
$16
22 days ago
(27-Oct-2026)
0/11 (0%)
$12.21 (322.16%)
Hold Since 05-Nov-2024
$4
$0.39 (10.80%)
$3
6 months 11 days ago
(07-May-2026)
4/5 (80%)
$-0.93 (-18.86%)
50
Buy Since 04-May-2026
$11
$7.39 (204.71%)
$6
6 months 14 days ago
(04-May-2026)
1/2 (50%)
$6.25 (131.58%)
391
Buy Since 28-Nov-2016
$12
$8.39 (232.41%)
6 months 14 days ago
(04-May-2026)
0/2 (0%)
$7.25 (152.63%)